What is Capsular Contracture?
Capsular contracture is the most common long-term complication following breast augmentation surgery. It occurs when the natural scar tissue (capsule) that forms around any breast implant becomes abnormally thick and tight, potentially causing discomfort, distortion, and aesthetic concerns.
The Baker Classification
Capsular contracture is graded using the Baker scale:
Grade I: The breast is normally soft and appears natural
Grade II: The breast is slightly firm but appears normal
Grade III: The breast is firm and appears abnormal (visible distortion)
Grade IV: The breast is hard, painful, and visibly distorted
Grades I and II are generally considered acceptable, while Grades III and IV typically require surgical intervention.
Why Does Capsular Contracture Occur?
Contributing Factors
Bacterial biofilm: Subclinical bacterial contamination is now considered the primary cause
Implant surface characteristics: Aggressive texturing can trigger inflammatory responses
Surgical technique: Excessive tissue trauma increases inflammatory mediators
Hematoma/seroma: Blood or fluid collections around the implant promote capsule formation
Patient factors: Individual healing responses, smoking, radiation history
How the Preservé Technique Reduces Risk
Tissue Preservation = Less Inflammation
The Preservé approach directly addresses multiple risk factors:
Reduced Bacterial Contamination
Minimal tissue handling reduces exposure to skin flora
Precise pocket creation limits dead space where bacteria can colonize
No-touch technique for implant insertion
Preserved Blood Supply
Intact vasculature delivers immune cells effectively
Better tissue oxygenation inhibits bacterial growth
Faster healing reduces the window of vulnerability
Minimal Hematoma Risk
Less cutting means less bleeding
Preserved tissue planes maintain natural hemostasis
Tumescent technique provides additional vasoconstriction
The SmoothSilk® Advantage
Motiva's SmoothSilk® Nano-Surface technology complements the Preservé technique:
Organized Tissue Response
Nano-scale surface promotes parallel collagen alignment
Organized capsule formation rather than chaotic scar tissue
Reduced chronic inflammatory stimulus
Anti-Biofilm Properties
Smooth nano-surface resists bacterial adhesion
Reduced surface area for biofilm formation
Lower chronic inflammatory load
Clinical Evidence
Capsular contracture rates consistently below 1% in published studies
Zero confirmed BIA-ALCL cases with SmoothSilk® surface
Superior long-term patient satisfaction scores
Prevention Strategies at Ryan Plastic Surgery
Dr. Choi employs a comprehensive prevention protocol:
Surgical Protocol
Strict aseptic technique throughout
Keller funnel (no-touch) implant insertion
Antibiotic pocket irrigation
Precise hemostasis before implant placement
Layered closure to eliminate dead space
Post-Operative Protocol
Early mobilization (within 24 hours)
Breast massage instruction (when appropriate)
Regular follow-up monitoring
Ultrasound assessment at 6 and 12 months
Results: Dr. Choi's 6-Year Data
From the ISAPS 2025 presentation (2,130 cases):
Baker Grade III-IV rate: Less than 1%
Reoperation for contracture: 0.4%
Average time to detection: 14 months (when it did occur)
All cases resolved with: Capsulectomy + implant exchange
What to Do If You Suspect Capsular Contracture
Signs to watch for:
Increasing firmness on one or both sides
Change in breast shape or position
Discomfort or tightness not present before
Visible rippling or distortion
If you notice these changes, schedule an evaluation promptly. Early intervention typically leads to better outcomes.
Conclusion
While capsular contracture cannot be completely eliminated, modern techniques have dramatically reduced its incidence. The combination of the Preservé tissue-preserving approach and Motiva SmoothSilk® technology represents the current gold standard for minimizing this complication.
If you have concerns about capsular contracture or are considering breast augmentation, schedule a consultation with Dr. Sangmun Choi at Ryan Plastic Surgery.